J&J's Cordis snaps up Flexible Stenting Solutions

March 12, 2013 by Brad Perriello

Johnson & Johnson's stenting arm, Cordis Corp. furthers its turn away from coronary stents toward the endovascular market with the acquisition of Flexible Stenting Solutions for an undisclosed amount.

Cordis Corp.

Cordis Corp., the stent-making arm of healthcare colossus Johnson & Johnson (NYSE:JNJ), said it's acquired Flexible Stenting Solutions as part of turning its back on the coronary stents market in favor of the endovascular arena.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.